Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.550
+0.040 (2.65%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$221,698
Profits / Employee
-$165,590
Market Cap
113.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CLLS News
- 6 weeks ago - Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update - GlobeNewsWire
- 7 weeks ago - Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - GlobeNewsWire
- 2 months ago - Cellectis Presents ‘Smart CAR T' Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewsWire
- 4 months ago - Cellectis: Poised To Start Answering Questions In 2025 - Seeking Alpha
- 4 months ago - Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB) - GlobeNewsWire
- 6 months ago - Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting - GlobeNewsWire
- 6 months ago - Cellectis S.A. (CLLS) Q3 2024 Earnings Call Transcript - Seeking Alpha